Presentation
Explicyte immuno-oncology offers preclinical contract research services for cancer immunotherapy drug discovery. Our preclinical CRO services range from (i) cell-based assays – for in vitro characterization of new anti-cancer immune modulators – (ii) in vivo proof-of-concept studies in validated syngeneic mouse tumor models (ii) to biomarker analysis through cutting-edge technologies such as digital histology, multispectral imaging as well as digital spatial profiling.
Contact
Address
229 Cours de l’Argonne, 33000 Bordeaux
Website
Targeted indications : breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, supportive care, liver cancer, brain cancer, head & neck cancer, gastrointestinal cancer, gynecological cancer, bone cancer, genitourinary cancer, skin cancer, hematologic cancer, lymphoma, myeloma, leukemia, predictive toxicology.